Bayer A.G. stock: contrarian Buy with €35 target. Click for this updated look at BAYZF stock prospects and why I am neutral ...
Bayer AG’s pharmaceuticals unit is on track for a return to growth as new drugs for cancer and kidney disease offset sales ...
Monsanto Company has two main operating divisions and key competitors within each sector, including The Mosaic Company, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results